StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CEL.TA$3518.00+0.34%
Fair $3518.00+0.0%

CEL.TA

Cellcom Israel Ltd.

Communication Services / Telecom ServicesTel Aviv

$3518.00

+12.00 (+0.34%)

Fairly Valued+0.0%Fair Value $3518.00Fund rank 36/100 · Data gapFallback financials|
SA 46/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $530.0M · quality 76.3/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 88/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

46/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · CEL.TALocal privado en este navegador · Cellcom Israel Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$5.9B

P/E

10.4x

↓

EV/EBITDA

337.1x

↑

ROE

19.9%

↑

Gross Margin

34.2%

↓

Debt/Equity

0.78

↑
52-Week Range$3518
$2120$4275

TradingView lightweight chart

CEL.TA price, volumen y niveles de valoración

Último $3,518Periodo -69.5%
Fair value: $3,518

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-0.4%

FCF CAGR

+6.4%

FCF margin

13.7%

FCF / Net income

1.03x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $4.24B · net income $564.0M · FCF $583.0M

2022-FY → 2025-FY

Gross margin

34.2%+4.8% pts

Operating margin

8.8%+1.5% pts

Net margin

13.3%+9.6% pts

FCF margin

13.7%+2.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$4.24B$4.24B$4.44B$4.40B$4.30B
Net Income$564.0M$564.0M$173.0M$134.0M$157.0M
EBITDA$1.78B$1.78B$1.31B$1.22B$1.20B
EPS3.313.311.040.810.95
Gross Margin34.2%34.2%31.7%30.4%29.4%
Operating Margin8.8%8.8%8.3%7.7%7.3%
Net Margin13.3%13.3%3.9%3.0%3.7%
Balance Sheet
Debt/Equity0.780.781.081.321.72
Current Ratio0.660.66———
Cash Flow
Free Cash Flow$583.0M$583.0M$530.0M$510.0M$484.0M
Returns
ROE19.9%19.9%7.1%5.9%7.5%
Valuation
P/E10.4110.412315.381933.331780.00
EV/EBITDA337.11337.11307.85215.71237.15
P/B211.53211.53163.29114.70133.57
Growth & Yield
Revenue Growth-4.5%-4.5%1.0%2.3%—
EPS Growth218.3%218.3%28.4%-14.7%—
Dividend Yield6.8%6.8%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

355.2%

muy exigente

EPS terminal req.

$312.16

Spread vs growth

-136.9%

5Y implied EPS CAGR

157.9%

muy exigente

EPS terminal req.

$377.72

Spread vs growth

60.4%

10Y implied EPS CAGR

68.4%

muy exigente

EPS terminal req.

$608.32

Spread vs growth

149.8%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +62.4%

Total return

+62.4%

Start / end P/E

2173.1x → 1062.8x

EPS bridge

1.04 → 3.31

Residual

-111.5%

EPS growth+218.3%
Multiple rerating-51.1%
Dividend+6.8%
Residual / FX / buybacks / cross-term-111.5%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.